[go: up one dir, main page]

TW207496B - Pharmaceutical composition for preventing or delaying the occurrence of dementia - Google Patents

Pharmaceutical composition for preventing or delaying the occurrence of dementia

Info

Publication number
TW207496B
TW207496B TW81107137A TW81107137A TW207496B TW 207496 B TW207496 B TW 207496B TW 81107137 A TW81107137 A TW 81107137A TW 81107137 A TW81107137 A TW 81107137A TW 207496 B TW207496 B TW 207496B
Authority
TW
Taiwan
Prior art keywords
dementia
delaying
occurrence
preventing
pharmaceutical composition
Prior art date
Application number
TW81107137A
Other languages
Chinese (zh)
Inventor
Patrick L Mcgeer
Nobuo Harada
Hiroshi Kimura
Edith G Mcgeer
Michael Schulzer
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of TW207496B publication Critical patent/TW207496B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention pertain to the novel use of 4,4'- diaminodiphonyloulfono and its didextrode sulfonate derivative and other closely related sulfones for preventing or delaying the occurrence of dementia (Alzheimer's disease). A method of treating dementia in a human being characterized by administering to the human being a therapeutic daily to weekly amount of a substance selected from the group consisting of 4,4'-diaminodiphenylsulfone, its didextrose sulfonate derivative, and other closely related sulfone derivatives, and therapeutically acceptable salts thereof.
TW81107137A 1991-04-23 1992-09-09 Pharmaceutical composition for preventing or delaying the occurrence of dementia TW207496B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68949891A 1991-04-23 1991-04-23

Publications (1)

Publication Number Publication Date
TW207496B true TW207496B (en) 1993-06-11

Family

ID=51356825

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81107137A TW207496B (en) 1991-04-23 1992-09-09 Pharmaceutical composition for preventing or delaying the occurrence of dementia

Country Status (1)

Country Link
TW (1) TW207496B (en)

Similar Documents

Publication Publication Date Title
HK1003978A1 (en) Composition for the treatment of schizophrenia
AU599792B2 (en) Anti-parkinsonian indolone derivatives
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
ATE204178T1 (en) METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN
HUT71344A (en) Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
HUP9802762A2 (en) Diphenylmethylene piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
DK0652000T3 (en) Use of 2-phenyl-3-aroylbenzothiophenes for the preparation of a drug for inhibiting angiogenesis and angiogenic diseases
ATE137965T1 (en) USE OF TOMOXETINE TO TREAT LOWER URINARY TRACT DISORDERS
GR3015014T3 (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts.
IL90056A (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
TR200101163T2 (en) Bile water substituted phenyl-alkenoylguanidines, production methods, uses
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
DE68927055D1 (en) 2 ', 5'-OLIGOADENYLATE DERIVATIVES FOR USE AS A MEDICINAL PRODUCT
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
IL109151A0 (en) Pharmaceutical preparations for the treatment of skin disorders
TW207496B (en) Pharmaceutical composition for preventing or delaying the occurrence of dementia
EP0314984A3 (en) Use of 2-pyrimidinyl-1-piperazine derivatives
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE121726T1 (en) HYDROQUINONE ESTERS OF AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM.
ES2065855A1 (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
FI894813A0 (en) Process for the preparation of therapeutically active 2-methoxycarbonyl-substituted N, N'-di (trimethoxybenzoyl) piperazine derivatives